Acuren Corp Files 8-K on Financials
Ticker: TICAW · Form: 8-K · Filed: Dec 20, 2024 · CIK: 2032966
| Field | Detail |
|---|---|
| Company | Acuren Corp (TICAW) |
| Form Type | 8-K |
| Filed Date | Dec 20, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, operations
TL;DR
Acuren Corp dropped an 8-K detailing financial results and operations.
AI Summary
Acuren Corp filed an 8-K on December 20, 2024, reporting on its Results of Operations and Financial Condition, and Financial Statements and Exhibits. The filing details the company's principal executive offices located at 14434 Medical Complex Drive, Suite 100, Tomball, Texas 77377, and its telephone number is 800-218-7450. Acuren Corp is incorporated in Delaware.
Why It Matters
This 8-K filing provides essential updates on Acuren Corp's financial condition and operations, which is crucial for investors and stakeholders to assess the company's performance.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of financial information and does not appear to contain any immediate or significant risks.
Key Players & Entities
- ACUREN CORP (company) — Registrant
- 14434 Medical Complex Drive, Suite 100, Tomball, Texas 77377 (location) — Principal executive offices
- 800-218-7450 (phone_number) — Registrant's telephone number
- Delaware (jurisdiction) — State of incorporation
FAQ
What is the primary purpose of this 8-K filing for Acuren Corp?
The primary purpose of this 8-K filing is to report on Acuren Corp's Results of Operations and Financial Condition, as well as Financial Statements and Exhibits.
When was this 8-K filing submitted?
This 8-K filing was submitted on December 20, 2024.
Where are Acuren Corp's principal executive offices located?
Acuren Corp's principal executive offices are located at 14434 Medical Complex Drive, Suite 100, Tomball, Texas 77377.
What is Acuren Corp's telephone number?
Acuren Corp's telephone number is 800-218-7450.
In which state was Acuren Corp incorporated?
Acuren Corp was incorporated in Delaware.
Filing Stats: 471 words · 2 min read · ~2 pages · Grade level 13.1 · Accepted 2024-12-20 08:00:10
Filing Documents
- ea0225308-8k_acuren.htm (8-K) — 24KB
- ea022530801ex99-1_acuren.htm (EX-99.1) — 169KB
- 0001213900-24-110769.txt ( ) — 377KB
- cik0002032966-20241220.xsd (EX-101.SCH) — 3KB
- cik0002032966-20241220_lab.xml (EX-101.LAB) — 33KB
- cik0002032966-20241220_pre.xml (EX-101.PRE) — 22KB
- ea0225308-8k_acuren_htm.xml (XML) — 3KB
02 Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition. On December 20, 2024, Acuren Corporation (the "Company") issued a press release announcing its financial results for the fiscal quarter ended September 30, 2024. A copy of the press release is furnished as Exhibit 99.1. The information furnished under this Item 2.02, including Exhibit 99.1, is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in any such filing, unless the Company expressly sets forth in such filing that such information is to be considered "filed" or incorporated by reference therein.
01 - Financial Statements and Exhibits
Item 9.01 - Financial Statements and Exhibits (d): The following exhibits are being filed herewith: Exhibit No. Description 99.1 Press Release Issued by Acuren Corporation on December 20, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 1 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Acuren Corporation Date: December 20, 2024 By: /s/ Kristin Schultes Name: Kristin Schultes Title: Chief Financial Officer 2